- Thursday, 16 May 2019
Article from The Australian Financial Review
Taking on disease through regenerative medicine
Regenerating every cell, tissue or organ in the body, curing genetic disorders and chronic diseases, alleviating pain and delaying the onset of ageing, these are the altruistic promises of stem cell therapy.
- Friday, 10 May 2019
Article from STAR INVESTING
Regeneus (ASX: RGS) has announced the appointments of John Chiplin, PhD and Alan W. Dunton, M.D. to its board of directors.
- Tuesday, 30 April 2019
Article from STOCKHEAD
Regenerative medicine company Regeneus has secured seasoned industry leaders to its board as it looks to make bigger noise overseas.